189 related articles for article (PubMed ID: 23587095)
1. Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay.
Mahler M; Gascon C; Patel S; Ceribelli A; Fritzler MJ; Swart A; Chan EK; Satoh M
Arthritis Res Ther; 2013 Apr; 15(2):R50. PubMed ID: 23587095
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.
Koenig M; Bentow C; Satoh M; Fritzler MJ; Senécal JL; Mahler M
Rheumatology (Oxford); 2019 Oct; 58(10):1784-1793. PubMed ID: 31323671
[TBL] [Abstract][Full Text] [Related]
4. What autoantibody tests should become widely available to help scleroderma diagnosis and management?
Muro Y; Sugiura K; Akiyama M
Arthritis Res Ther; 2013 Jul; 15(4):116. PubMed ID: 23856077
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
[TBL] [Abstract][Full Text] [Related]
7. Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex.
Mecoli CA; Adler BL; Yang Q; Hummers LK; Rosen A; Casciola-Rosen L; Shah AA
Arthritis Rheumatol; 2021 Feb; 73(2):315-323. PubMed ID: 33241644
[TBL] [Abstract][Full Text] [Related]
8. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen.
Mahler M; Fritzler MJ; Satoh M
Autoimmun Rev; 2015 Mar; 14(3):254-7. PubMed ID: 25462581
[TBL] [Abstract][Full Text] [Related]
10. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
Kuwana M; Kimura K; Hirakata M; Kawakami Y; Ikeda Y
Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
[TBL] [Abstract][Full Text] [Related]
11. PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays.
Mecoli CA; Gutierrez-Alamillo L; Yang Q; Sampedro M; Woods A; Hummers LK; Wigley F; Shah AA; Casciola-Rosen L
Clin Rheumatol; 2021 Jul; 40(7):2763-2769. PubMed ID: 33459953
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
[TBL] [Abstract][Full Text] [Related]
13. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
14. Identity of the RNase MRP- and RNase P-associated Th/To autoantigen.
Van Eenennaam H; Vogelzangs JH; Lugtenberg D; Van Den Hoogen FH; Van Venrooij WJ; Pruijn GJ
Arthritis Rheum; 2002 Dec; 46(12):3266-72. PubMed ID: 12483731
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.
Perosa F; Favoino E; Cuomo G; Digiglio L; Dammacco F; Prete M; Valentini G; Racanelli V
Arthritis Res Ther; 2013 Jul; 15(4):R72. PubMed ID: 23837651
[TBL] [Abstract][Full Text] [Related]
16. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis.
Codullo V; Morozzi G; Bardoni A; Salvini R; Deleonardi G; De Pità O; Riccieri V; Ruffatti A; Tincani A; Tozzoli R; Valesini G; Montecucco C;
Clin Exp Rheumatol; 2007; 25(3):373-7. PubMed ID: 17631732
[TBL] [Abstract][Full Text] [Related]
17. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
Harvey G; Black C; Maddison P; McHugh N
J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
[TBL] [Abstract][Full Text] [Related]
19. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
20. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
